It has been reported that pharmacological inhibition of PPARγ1 promoter DNA methylation via 5-aza-2′-deoxycytidine or genetically by DNMT1 knockout promotes macrophage alternative activation in obesity (Wang et al., 2016). This evidence concerns the gene DNMT1 and obesity due to melanocortin 4 receptor deficiency.